Nanotechnology Based Medications of Photo Dynamic Therapy for Cancer Diseases
[1]
Maskia Rahman, Electronics and Communication Engineering, Khulna University, Khulna, Bangladesh.
[2]
Md. Mehedi Hasan, Space Science Centre (ANGKASA), Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Deregulation of cell growth and development lead to cancer, a severe condition that claims millions of lives worldwide. Targeted or selective approaches used during cancer treatment determine the efficacy and outcome of the therapy. Photo dynamic therapy (PDT) is a favourable option attitude for enhanced cancer disease treatment. In PDT, a photosensitizer (PS) is regulated that and enacted by the light of a particular wavelength, that causes specific harm to the tumour. The achievement of PDT is constrained by the trouble in controlling photosensitizers with low water solubility. Nanotechnology in medicine uses tiny particles (109 meters in length) to help deliver drugs to places that need them. Nanotechnology based medication conveyance frameworks may enhance the transcytosis of a PS across over epithelial and endothelial obstructions and manage the synchronous co-conveyance of at least two medications. One profound use for nanotechnology has been the treatment of cancer, a notoriously difficult cancer to treat using traditional chemotherapy. One of the most fascinating uses for nanotechnology is the various kinds of drug delivery that can be done using it. So, the utilization of nanotechnology in medication may offer various energizing conceivable outcomes in tumour treatment and enhance the viability of accessible therapeuticsnt. This paper summarizes the development of nanoparticles for efficient photodynamic therapy for cancer diseases.
Cancer Diseases, Medications, Nanotechnology, Photo Dynamic Therapy
[1]
M. Fink, H. Ermert, S. Lyer and C. Alexiou, “Sonographic detection of magnetic nanoparticles for Magnetic Drug Targeting using coded magnetic fields”, IEEE International Conferences on Ultrasonics Symposium, 2016, Doi: 10.1109/ULTSYM.2016.7728404.
[2]
J. L. Fleck and C. G. Cassandras, “Personalized cancer therapy design: Robustness vs. optimality”, IEEE Conference on Decision and Control (CDC), 2016, Doi: 10.1109/CDC.2016.7799040.
[3]
G. Giordano, A. Rantzer and V. D. Jonsson, “A convex optimization approach to cancer treatment to address tumor heterogeneity and imperfect drug penetration in physiological compartments”, IEEE Conference on Decision and Control (CDC), 2016, Doi: 10.1109/CDC.2016.7798636.
[4]
B. Yu, “Quantitative optical spectroscopy and imaging for cancer diagnosis and treatment monitoring”, Electromagnetic Research Symposium, 2016, Doi: 10.1109/PIERS.2016.7734946.
[5]
A. Babu, R. Muralidharan and N. Amreddy, “Nanoparticles for siRNA-based gene silencing in tumor therapy”, IEEE Transactions on NanoBioscience, 2016, Doi: 10.1109/TNB.2016.2621730.
[6]
M. M. Hasan and M. F. Hossain, “Facial features detection in color images based on skin color segmentation”, IEEE International Conference on Informatics, Electronics & Vision (ICIEV), 2014, pp.1-5, Doi: 10.1109/ICIEV.2014.6850763.
[7]
F. H. Shashi, I. Misbah and S. A. Muyeed, “Absorption properties of Silver-Silica-Gold Nanomatryushka particle and its optimization for photo-thermal cancer therapy”, IEEE International Conference on Informatics, Electronics and Vision (ICIEV), 2016, Doi: 10.1109/ICIEV.2016.7760099.
[8]
J. Guo, G. Chen, J. Wu and C. T. Chin, “Passive delivery of liposomes to mouse brain after blood-brain barrier opening induced by focused ultrasound with microbubbles”, IEEE International Ultrasonics Symposium (IUS), 2015, Doi: 10.1109/ULTSYM.2015.0405.
[9]
T. Dumitriu, R. P. Dumitriu and V. Manta, “Application of Artificial Neural Networks for modeling drug release from a bicomponent hydrogel system”, International Conference on System Theory, Control and Computing (ICSTCC), 2016, Doi: 10.1109/ICSTCC.2016.7790744.
[10]
R. Chuealee, P. Aramwit and T. Srichana, “Characteristics of Cholesteryl Cetyl Carbonate Liquid Crystals as Drug Delivery Systems”, IEEE International Conference on Nano/Micro Engineered and Molecular Systems, 2007, Doi: 10.1109/NEMS.2007.352210.
[11]
A. M. Caminade, C. O. Turrin and J. P. Majoral, “Biological properties of water-soluble phosphorhydrazone dendrimers”, Braz. J. Pharm. Sci., 2013, 49, 33–44.
[12]
N. Challapalli, M. E. Ahsen and M. Vidyasagar, “Modelling drug response and resistance in cancer: Opportunities and challenges”, IEEE Conference on Decision and Control (CDC), 2016, Doi: 10.1109/CDC.2016.7798635.
